BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15044484)

  • 1. Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation.
    Lin MT; Chang CC; Chen ST; Chang HL; Su JL; Chau YP; Kuo ML
    J Biol Chem; 2004 Jun; 279(23):24015-23. PubMed ID: 15044484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.
    Menendez JA; Vellon L; Mehmi I; Teng PK; Griggs DW; Lupu R
    Oncogene; 2005 Jan; 24(5):761-79. PubMed ID: 15592521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5.
    Crockett JC; Schütze N; Tosh D; Jatzke S; Duthie A; Jakob F; Rogers MJ
    Endocrinology; 2007 Dec; 148(12):5761-8. PubMed ID: 17823253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway.
    Lin MT; Zuon CY; Chang CC; Chen ST; Chen CP; Lin BR; Wang MY; Jeng YM; Chang KJ; Lee PH; Chen WJ; Kuo ML
    Clin Cancer Res; 2005 Aug; 11(16):5809-20. PubMed ID: 16115920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer.
    Vellon L; Menendez JA; Lupu R
    Oncogene; 2005 May; 24(23):3759-73. PubMed ID: 15782133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin alpha2beta1.
    Lin MT; Chang CC; Lin BR; Yang HY; Chu CY; Wu MH; Kuo ML
    J Biol Chem; 2007 Nov; 282(47):34594-604. PubMed ID: 17905740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of hypoxia-inducing factor-1alpha-dependent plasminogen activator inhibitor-1 up-regulation in Cyr61/CCN1-induced gastric cancer cell invasion.
    Lin MT; Kuo IH; Chang CC; Chu CY; Chen HY; Lin BR; Sureshbabu M; Shih HJ; Kuo ML
    J Biol Chem; 2008 Jun; 283(23):15807-15. PubMed ID: 18381294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyr61 induces the expression of monocyte chemoattractant protein-1 via the integrin ανβ3, FAK, PI3K/Akt, and NF-κB pathways in retinal vascular endothelial cells.
    You JJ; Yang CH; Yang CM; Chen MS
    Cell Signal; 2014 Jan; 26(1):133-40. PubMed ID: 24063814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease.
    Xie D; Miller CW; O'Kelly J; Nakachi K; Sakashita A; Said JW; Gornbein J; Koeffler HP
    J Biol Chem; 2001 Apr; 276(17):14187-94. PubMed ID: 11297518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyr61 suppresses growth of human endometrial cancer cells.
    Chien W; Kumagai T; Miller CW; Desmond JC; Frank JM; Said JW; Koeffler HP
    J Biol Chem; 2004 Dec; 279(51):53087-96. PubMed ID: 15471875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB and is independent from AKT.
    Machuca C; Mendoza-Milla C; Córdova E; Mejía S; Covarrubias L; Ventura J; Zentella A
    BMC Cell Biol; 2006 Feb; 7():9. PubMed ID: 16504042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
    Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
    Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells.
    Huang Y; Johnson KR; Norris JS; Fan W
    Cancer Res; 2000 Aug; 60(16):4426-32. PubMed ID: 10969788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of angiogenic factor Cyr61 during neuronal cell death via the activation of c-Jun N-terminal kinase and serum response factor.
    Kim KH; Min YK; Baik JH; Lau LF; Chaqour B; Chung KC
    J Biol Chem; 2003 Apr; 278(16):13847-54. PubMed ID: 12576482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of NF-kappaB activation in a H4IIE transfectant insensitive to doxorubicin-induced apoptosis.
    Chovolou Y; Wätjen W; Kampkötter A; Kahl R
    Toxicology; 2007 Mar; 232(1-2):89-98. PubMed ID: 17223244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells.
    Ju JH; Jang K; Lee KM; Kim M; Kim J; Yi JY; Noh DY; Shin I
    Carcinogenesis; 2011 Oct; 32(10):1474-83. PubMed ID: 21798852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyr61 increases matrix metalloproteinase-3 expression and cell motility in human oral squamous cell carcinoma cells.
    Chuang JY; Yu NY; Chiang IP; Lai CH; Lin CD; Tang CH
    J Cell Biochem; 2012 Jun; 113(6):1977-86. PubMed ID: 22253074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer.
    Sampath D; Winneker RC; Zhang Z
    Endocrinology; 2001 Jun; 142(6):2540-8. PubMed ID: 11356703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and regulation of Cyr61 in human breast cancer cell lines.
    Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
    Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked regression of liver metastasis by combined therapy of ultrasound-mediated NF kappaB-decoy transfer and transportal injection of paclitaxel, in mouse.
    Azuma H; Tomita N; Sakamoto T; Kiyama S; Inamoto T; Takahara K; Kotake Y; Segawa N; Morishita R; Takahara S; Hayasaki H; Otsuki Y; Horie S; Tanigawa N; Katsuoka Y
    Int J Cancer; 2008 Apr; 122(7):1645-56. PubMed ID: 18058816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.